“The litigation is behind us”, the European Commission’s health spokesman insisted repeatedly on Friday 3 September, as he answered journalists’ questions about the agreement announced a few hours earlier between the European Commission and the pharmaceutical company AstraZeneca.
The two parties, who have been engaged in legal proceedings since April (see EUROPE B12718A4), finally opted for an amicable resolution of their dispute.
It was agreed that AstraZeneca would deliver the...